Major US Advisory Committee to Vote on Modifying Baby Hepatitis B Vaccine Recommendation
Following a hold-up and a remarkably divisive meeting, a government vaccine expert group was scheduled to decide on Friday on whether to change the longstanding recommendation that each baby be vaccinated against hepatitis B.
Intense Discussion and a Postponed Decision
The initial day of the conference on Thursday was defined by intense argument over limiting availability to the hepatitis B vaccine for infants and a choice to defer the vote by a day to allow panelists additional time to examine the language. The committee, which guides the CDC on vaccination protocols, had twice before postponed.
“Is there any definitive data of damage of giving this vaccination before 30 days? Or is this conjecture?” asked one committee member.
In reply, another participant stated, “There is scant proof about the enduring danger.”
Existing Recommendations and Potential Impact
The injection is presently advised for each baby within 24 hours of delivery to prevent infection of hepatitis B, which can result in major damage to the liver. It has been given to over a billion individuals for over thirty years.
The Georgia assembly presented no recent proof of injuries resulting from the vaccine. Specialists note any change to the existing hepatitis B immunization timeline could have significant and far-reaching implications for pediatric well-being in the United States.
Committee Makeup and Latest Shifts
The advisory panel can only provide advice to the director of the CDC. The panel's membership has experienced alterations in recent days, with the statement that the group's former head would step down for an official role and be substituted with a heart specialist who has been questioning of other inoculations.
The board includes a number of immunization doubters who align with a aim to revamp – and possibly, in some cases, eliminate – long-established vaccination recommendations.
